Page last updated: 2024-08-23

paclitaxel and Cirrhoses, Experimental Liver

paclitaxel has been researched along with Cirrhoses, Experimental Liver in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, J; Feng, GG; Huang, L; Ishikawa, N; Ito, Y; Koide, T; Kurokawa, T; Li, C; Nonami, T; Sugiyama, S; Tsunekawa, K1

Other Studies

1 other study(ies) available for paclitaxel and Cirrhoses, Experimental Liver

ArticleYear
Roles of naofen, a novel WD-repeat-2 protein, in the CCl4-treated livers--a possible relationship to cell proliferation.
    European journal of pharmacology, 2008, Jun-10, Volume: 587, Issue:1-3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carbon Tetrachloride Poisoning; Cell Count; Cell Line; Cell Proliferation; Cells, Cultured; Hepatectomy; Hepatocytes; Humans; Immunohistochemistry; In Situ Hybridization; Kinetics; Liver; Liver Cirrhosis, Experimental; Male; Mitosis; Paclitaxel; Proteins; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A

2008